Inflammation in CNS Neurodegenerative Diseases.
This article is protected by copyright. All rights reserved. PMID: 29513402 [PubMed - as supplied by publisher]
The University of Rochester Medical Center (URMC), Burke Neurological Institute, and Wadsworth Center of the New York State Department of Health (NYSDOH) have been awarded a $5 million grant from the Empire State Development Corporation to speed the development of ground-breaking neurological treatments for those disabled from stroke.
Publication date: Available online 19 May 2019Source: SeizureAuthor(s): Alessandro Iodice, Carlotta Spagnoli, Daniele Frattini, Grazia Gabriella Salerno, Susanna Rizzi, Carlo Fusco
This study uses a qualitative computational approach—combining temporal and semantic information—to investigate exploitation and exploration patterns as indicators for semantic memory retrieval and executive control processes. Audio SVF recordings of 20 controls (C, 66–81 years), 55 MCI (57–94 years) and 20 AD subjects (66–82 years) were assessed while groups were matched according to age and education. All groups produced, on average, the same amount of semantically related items in rapid succession within word clusters. Conversely, towards AD, there was a clear decline in semantic as well as...
We describe the clinical features and course of a patient harboring the rare p.V32A (c.155T>C) variant that was previously described in only two patients and whose pathogenicity was unclear.
Condition: Stroke Intervention: Device: Repetitive peripheral nerve stimulation Sponsors: Hospital Israelita Albert Einstein; Fundação de Amparo à Pesquisa do Estado de São Paulo Not yet recruiting
Condition: Stroke Intervention: Other: A co-design phase aims to ensure the feasibility and relevance of the proposed intervention and evaluation. Sponsor: Hospices Civils de Lyon Not yet recruiting
Conditions: Acute Ischemic Stroke; Intracranial Stenosis Intervention: Device: Treatment with Credo® stent together with the NeuroSpeed® PTA balloon catheter. Sponsor: Acandis GmbH Recruiting
Conditions: Alzheimer Dementia; Alzheimer Disease Intervention: Drug: Contraloid Sponsors: Prof. Dr. Dieter Willbold; Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany; Medical University of Vienna; NeuroScios, Austria; Nuvisan, Germany; Fundación Teófilo Hernando, Spain; Alzheimer's Association Completed
ConclusionsIL-6 leads to PCa resistance to radiation through upregulation of DNA repair associated molecules ATM, ATR, BRCA1, and BRCA2.
Chief pharmacist Graham Parsons details a typical day working for the leading social enterprise, Turning Point, which supports clients with learning disabilities, mental health, drug and alcohol problems.